Proceeds from disposition of marketable securities and other investments
Medtronic Proceeds from disposition of marketable securities and other investments decreased by 10.3% to $2.01B in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 6.8%, from $2.16B to $2.01B. Over 4 years (FY 2021 to FY 2025), Proceeds from disposition of marketable securities and other investments shows a downward trend with a -7.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher proceeds indicate the conversion of financial assets into cash, potentially to fund operations or debt repayment.
Detailed definition
Represents cash inflows from the liquidation, maturity, or collection of financial investments. This provides a source o...
Peer comparison
Standard investing activity; common across companies with active treasury management.
investing_proceeds_from_sale_maturity_and_collections_of_b77387Historical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.59B | $2.32B | $1.29B | $3.52B | $2.56B | $1.89B | $1.45B | $2.05B | $1.96B | $1.75B | $2.59B | $804.00M | $2.30B | $2.16B | $1.80B | $2.30B | $2.24B | $2.01B |
| QoQ Change | — | -49.4% | -44.7% | +174.0% | -27.2% | -26.4% | -23.1% | +41.4% | -4.6% | -10.6% | +48.2% | -69.0% | +185.9% | -6.2% | -16.5% | +27.5% | -2.5% | -10.3% |
| YoY Change | — | — | — | — | -44.2% | -18.8% | +12.8% | -41.7% | -23.7% | -7.3% | +78.6% | -60.8% | +17.5% | +23.4% | -30.5% | +185.7% | -2.6% | -6.8% |
Proceeds from disposition of marketable securities and other investments at Other Companies
Frequently Asked Questions
- What is Medtronic's proceeds from disposition of marketable securities and other investments?
- Medtronic (MDT) reported proceeds from disposition of marketable securities and other investments of $2.01B in Q2 2025.
- How has Medtronic's proceeds from disposition of marketable securities and other investments changed year-over-year?
- Medtronic's proceeds from disposition of marketable securities and other investments decreased by 6.8% year-over-year, from $2.16B to $2.01B.
- What is the long-term trend for Medtronic's proceeds from disposition of marketable securities and other investments?
- Over 4 years (2021 to 2025), Medtronic's proceeds from disposition of marketable securities and other investments has grown at a -7.0% compound annual growth rate (CAGR), from $11.35B to $8.50B.
- What does proceeds from disposition of marketable securities and other investments mean?
- Cash received from selling or maturing financial investments.